Non-Hodgkin Lymphoma Refractory/ Relapsed Clinical Trials

5 clinical trials for Non-Hodgkin Lymphoma Refractory/ Relapsed across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — RECRUITING · PHASE3
• This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Amping up With PemJAK — RECRUITING · PHASE2
• Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL — RECRUITING · PHASE2
• Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search